MYL

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

Trade of the Day: Teva Pharmaceuticals (TEVA) and Mylan (MYL)

Recent price shocks in biotech stocks is a good example of the risks investors may be exposed to as healthcare continues to become more complicated. More 

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More 

4 Pharmaceutical Stocks to Buy Now

The grades of four pharmaceutical stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall ratings on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy"). More 

MYL Earnings Momentum Propels Mylan Stock to a Buy

Biogeneric drugmaker Mylan is undergoing soaring growth based on its backlog of generics waiting for U.S government approval to market. Mylan stock is a buy More 

4 Pharmaceutical Stocks to Buy Now

This week, four pharmaceutical stocks are improving their overall rating on Portfolio Grader. Each of these rates an "A" ("strong buy") or "B" overall ("buy"). More